From the Publisher
A welcome letter from ACT's Publisher Wayne Blow
Dear Colleague,
Welcome to the Applied Clinical Trials' Directory & Buyers' Guide for 2006. Enclosed within these pages is a comprehensive list of key leaders and resources in the clinical trials industry. We know you will find a great deal of information to facilitate your search for suppliers and outsourcers of Clinical Packaging, Consulting, CROs, Contract Research Services, Information Technology, IRBs, Laboratories and Laboratory Supplies, Subject Recruitment, and Training and Education within the industry.
Wayne K. Blow
The clinical trials community is continually growing, and it is important to keep up with the changing environment. The purpose of this directory and buyers' guide is to keep you abreast of the changes taking place, whether they are in clinical trials monitoring, specialty labs, EDC suppliers, software developers or training and education. Clinical trials require strategic partners and outsourcers who will provide solutions to challenges, and they can be easily accessed within these pages.
Whether you are looking for a particular company or researching CROs, you will find what you need quickly in the ACT Directory & Buyers' Guide. While clinical trials colleagues communicate with you via the Internet, direct mail or at workshops and conferences, this single-source, desktop print directory will have distinct advantages. The directory is set up with a comprehensive category list and an alphabetized index. The directory also includes a section on professional societies and associations and a calendar of clinical trials events.
I hope our ACT 2006 Directory & Buyers' Guide proves to be an essential part of your desktop reference tools.
Best regards,
Wayne K. Blow
Publisher, Applied Clinical Trials
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
